Search

Pages

1. • Speech

   • 

   Comparison of pathological response observed on colorectal cancer metastases resected after different preoperative treatments

   Van den Eynde, Marc[UCL] Gizzi, Marco[UCL] Pairet, Géraldine[UCL] Lefevre, P Lannoy, Valérie[UCL] Gigot, Jean-François[UCL] Navez, Benoît[UCL] Canon, Jean-Luc Sempoux, Christine[UCL] Carrasco, Javier (2012) ESMO 2012 Congress — (Austria) Vienna
2. • Speech

   • 

   599P R-IMMUNE: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with locally advanced rectal cancer (LARC)

   Carrasco, Javier Beniuga, Gabriela[UCL] Mourin, Anne[UCL] Baldin, Paméla[UCL] Sinapi, Isabelle Schroeder, David De Cuyper, Astrid[UCL] Sclafani, Francesco Hendlisz, Alain van Laethem, Jean-Luc Boulanger, Anne-Sophie Van Ooteghem, Geneviève[UCL] Dermine, Alexandre Delmarcelle, Sophie Huyghe, Nicolas[UCL] Bar, Isabelle Van den Eynde, Marc[UCL] (2023) ESMO Congress 2023 — (Spain) Madrid
3. • Speech

   • 

   Interim analysis of the AVETUXIRI Trial: Avelumab combined with cetuximab and irinotecan for treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC)—A proof of concept, open-label, nonrandomized phase IIa study.

   Van den Eynde, Marc[UCL] Huyghe, Nicolas De Cuyper, Astrid[UCL] Sinapi, Isabelle Ferrier, Marie Gilet, Mélanie Van Maanen, Aline[UCL] Castella, Marie-Laure[UCL] Galon, Jerome Carrasco, Javier (2021) 2021 Gastrointestinal Cancers Symposium —
4. • Speech

   • 

   REGINA: A phase II trial of neoadjuvant regorafenib (Rego) in combination with nivolumab (Nivo) and short-course radiotherapy (SCRT) in intermediate-risk, stage II-III rectal cancer (RC).

   Bregni, Giacomo Senti, Chiara Acedo Reina, Elena Gkolfakis, Paraskevas Moretti, Luigi Veron, Ana Demetter, Pieter Liberale, Gabriel Carrasco, Javier Geboes, Karen Paula Gokburun, Yeter Peeters, Marc Van den Eynde, Marc[UCL] Van Laethem, Jean-Luc Vergauwe, Philippe Buyse, Marc E. Deleporte, Amélie Hendlisz, Alain Sclafani, Francesco (2022) 2022 ASCO Gastrointestinal Cancers Symposium —
5. • Speech

   • 

   Abstract CT123: A phase I study assessing the safety and clinical activity of multiple doses of a NKG2D-based CAR-T therapy, CYAD-01, administered concurrently with the neoadjuvant FOLFOX treatment in patients with potentially resectable liver metastases from colorectal cancer

   Lonez, Caroline Hendlisz, Alain Shaza, Leila Aftimos, Philippe Awada, Ahmad Machiels, Jean-Pascal[UCL] Van den Eynde, Marc[UCL] Canon, Jean-Luc Carrasco, Javier Verma, Bikash Gilham, David E. Lehmann, Frédéric F. (2018) Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; — Chicago, IL
6. • Speech

   • 

   Characterization of the immune microenvironment of synchronous primary tumor and liver colorectal metastases

   Van den Eynde, Marc[UCL] Mlecnik, Bernhard Machiels, Jean-Pascal[UCL] Debetancourt, Daphné[UCL] Bindea, Gabriela Mourin, Anne[UCL] Sempoux, Christine[UCL] Carrasco, Javier Gigot, Jean-François[UCL] Hubert, Catherine[UCL] Humblet, Yves[UCL] Haicheur, Nacilla Marliot, Florence Pages, Franck Galon, Jerome (2015) 2015 ASCO Annual Meeting — (United States) Chicago, IL
7. • Journal article

   • 

   Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial.

   Vandeputte, Caroline Bregni, Giacomo Gkolfakis, Paraskevas Guiot, Thomas Pretta, Andrea Kehagias, Pashalina Senti, Chiara Reina, Elena Acedo Van Bogaert, Camille Deleporte, Amélie Geboes, Karen Delaunoit, Thierry Demolin, Gauthier Peeters, Marc D'Hondt, Lionel[UCL] Janssens, Jos Carrasco, Javier Holbrechts, Stephane Goeminne, Jean-Charles[UCL] Vergauwe, Philippe Van Laethem, Jean-Luc Flamen, Patrick Hendlisz, Alain Sclafani, Francesco (2021) Clinical colorectal cancer — Vol. 20, no. 4, p. 326-333 (2021)
8. • Speech

   • 

   Randomized phase II studies comparing pathological responses observed on colorectal cancer metastases resected after preoperative treatment combining bevacizumab or cetuximab with FOLFOX or FOLFIRI.

   Van den Eynde, Marc[UCL] Castella, Marie-Laure[UCL] Machiels, Jean-Pascal[UCL] Humblet, Yves[UCL] Canon, Jean-Luc Houbiers, Ghislain Demolin, Gauthier D'Hondt, Lionel[UCL] Coche, Jean-Charles Van Daele, Daniel Delaunoit, Thierry Goeminne, Jean-Charles Benuiga, Gabriella Pairet, Géraldine Sempoux, Christine[UCL] Mourin, Anne[UCL] van Maalen, Aline[UCL] Carrasco, Javier (2015) 2015 ASCO GI — (United States) San Francisco, CA
9. • Journal article

   • 

   A short treatment with galactomannan GM-CT-01 corrects the functions of freshly isolated human tumor-infiltrating lymphocytes.

   Demotte, Nathalie[UCL] Bigirimana, René[USL-B] Wieërs, Grégoire Stroobant, Vincent[UCL] Squifflet, Jean-Luc[UCL] Carrasco, Javier Thielemans, Kris Baurain, Jean-François Van Der Smissen, Patrick Courtoy, Pierre J[UCL] van der Bruggen, Pierre[UCL] (2014) Clinical cancer research : an official journal of the American Association for Cancer Research — Vol. 20, no.7, p. 1823-33 (2014)
10. • Journal article

    • 

    A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice

    Demotte, Nathalie[UCL] Wieers, Grégoire[UCL] Van Der Smissen, Patrick[UCL] Moser, Muriel Schmidt, Christopher Thielemans, Kris Squifflet, Jean-Luc[UCL] Weynand, Birgit[UCL] Carrasco, Javier[UCL] Lurquin, Christophe[UCL] Courtoy, Pierre J.[UCL] van der Bruggen, Pierre[UCL] (2010) Cancer Research — Vol. 70, no. 19, p. 7476-7488 (2010)
11. • Speech

    • 

    635P Avelumab (AVE) combined with cetuximab (CET) and irinotecan (IRI) for the treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): The AVETUXIRI phase II study

    Van den Eynde, Marc[UCL] Huyghe, Nicolas[UCL] Sinapi, Isabelle De Cuyper, Astrid[UCL] Verstraelen, Eleonore Goffette, Pierre[UCL] Ghaye, Benoît[UCL] Papier, Matthias Bedognetti, Davide van Maanen, Aline[UCL] Castella, Marie-Laure[UCL] Galon, Jerôme Carrasco, Javier (2023) ESMO Congress 2023 — (Spain) Madrid
12. • Journal article

    • 

    Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer

    Bregni, Giacomo Vandeputte, Caroline Pretta, Andrea Senti, Chiara Trevisi, Elena Acedo Reina, Elena Kehagias, Pashalina Liberale, Gabriel Moretti, Luigi Bali, Maria Antonietta Demetter, Pieter Flamen, Patrick Carrasco, Javier D'Hondt, Lionel[UCL] Geboes, Karen Gokburun, Yeter Peeters, Marc Van den Eynde, Marc[UCL] Van Laethem, Jean-Luc Vergauwe, Philippe Chapot, Camille Anastasia Buyse, Marc Deleporte, Amelie Hendlisz, Alain Sclafani, Francesco (2021) Acta oncologica — Vol. 60, no. 4, p. 549-553 (2021)
13. • Journal article

    • 

    Vaccination of a Melanoma Patient with Mature Dendritic Cells Pulsed with MAGE-3 Peptides Triggers the Activity of Nonvaccine Anti-Tumor Cells.

    Carrasco, Javier[UCL] Van Pel, Aline[UCL] Neyns, Bart Lethé, Bernard Brasseur, Francis Renkvist, Nicolina van der Bruggen, Pierre[UCL] van Baren, Nicolas Paulus, Robert Thielemans, Kris Boon, Thierry Godelaine, Danièle (2008) Journal of Immunology — Vol. 180, no. 5, p. 3585-93 (2008)
14. • Speech

    • 

    Interim analysis of the phase II AVETUXIRI trial: Avelumab combined with cetuximab and irinotecan for treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC).

    Huyghe, Nicolas[UCL] De Cuyper, Astrid[UCL] Sinapi, Isabelle Vempalli, Fazulur Rehaman Rinchai, Darawan Beyaert, Simon[UCL] Verstraelen, Eleonore Goffette, Pierre[UCL] Ghaye, Benoît[UCL] Gilet, Mélanie Van Maanen, Aline[UCL] Castella, Marie-Laure[UCL] Mlecnik, Bernhard Carrasco, Javier Galon, Jerome Bedognetti, Davide Van den Eynde, Marc[UCL] (2022) 2022 ASCO Annual Meeting I —
15. • Speech

    • 

    Analysis of T-cell repertoires in early-stage breast carcinomas to evaluate tumor immunogenicity

    Carrasco, Javier Schröder, David[UCL] Galant, Christine[UCL] Berlière, Martine[UCL] Canon, Jean-Luc Machiels, Jean-Pascal[UCL] Delrée, Paul Hilbert, Pascale[UCL] Duhoux, François[UCL] Bar, Isabelle[UCL] Coulie, Pierre G.[UCL] (2017) Annual Meeting of the American Society of Clinical Oncology (ASCO) — Chicago, IL, USA
16. • Journal article

    • 

    Paired Rheumatoid Arthritis Synovial Biopsies From Small and Large Joints Show Similar Global Transcriptomic Patterns With Enrichment of Private Specificity and TCR Signaling Pathways.

    Triaille, Clément[UCL] Vansteenkiste, Louise[UCL] Constant, Manuel Ambroise, Jérôme[UCL] Méric de Bellefon, Laurent[UCL] Nzeusseu Toukap, Adrien[UCL] Sokolova, Tatiana[UCL] Galant, Christine[UCL] Coulie, Pierre G.[UCL] Carrasco, Javier Durez, Patrick[UCL] Lauwerys, Bernard[UCL] (2020) Frontiers in immunology — Vol. 11, p. 593083 [1-9] (2020)
17. • Journal article

    • 

    Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival.

    Mlecnik, Bernhard Van den Eynde, Marc[UCL] Bindea, Gabriela Church, Sarah E Vasaturo, Angela Fredriksen, Tessa Lafontaine, Lucie Haicheur, Nacilla Marliot, Florence Debetancourt, Daphné Pairet, Géraldine[UCL] Mourin, Anne[UCL] Gigot, Jean-François[UCL] Hubert, Catherine[UCL] Danse, Etienne[UCL] Dragean, Cristina[UCL] Carrasco, Javier Humblet, Yves[UCL] Valge-Archer, Viia Berger, Anne Pagès, Franck Machiels, Jean-Pascal[UCL] Galon, Jérôme (2018) Journal of the National Cancer Institute — Vol. 110, no. 1, p. 97-108 (2018)
18. • Speech

    • 

    Prognostic histological factors in resected colorectal liver metastasis with preoperative treatment

    Baldin, Paméla[UCL] Van den Eynde, Marc[UCL] Mlecnik, Bernhard Bindea, Gabriela Beniuga, Gabiela Carrasco, Javier Hubert, Catherine[UCL] Navez, Benoît[UCL] Pairet, Géraldine Mourin, Anne[UCL] Galon, Jerome Komuta, Mina[UCL] (2017) 68th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2017 — (United States) Washington, DC
19. • Journal article

    • 

    Chimeric Antigen Receptor-T Cells for Targeting Solid Tumors: Current Challenges and Existing Strategies.

    Springuel, Lorraine Lonez, Caroline Alexandre, Bertrand Van Cutsem, Eric Machiels, Jean-Pascal[UCL] Van Den Eynde, Marc[UCL] Prenen, Hans Hendlisz, Alain Shaza, Leila Carrasco, Javier Canon, Jean-Luc Opyrchal, Mateusz Odunsi, Kunle Rottey, Sylvie Gilham, David E Flament, Anne Lehmann, Frédéric F (2019) BioDrugs — Vol. 33, no. 5, p. 515-537 (2019)
20. • Speech

    • 

    2237P Avelumab (AVE), cetuximab (CET) and irinotecan (IRI) for treatment refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Translational analyses of the AVETUXIRI phase II trial

    Huyghe, Nicolas[UCL] Benidovskaya, Elena[UCL] Masoodi, Tariq Carrasco, Javier De Cuyper, Astrid[UCL] Sinapi, Isabelle Vempalli, Fazulur Verstraelen, Eleonore Goffette, Pierre[UCL] Ghaye, Benoît[UCL] Papier, M. Bedognetti, Davide van Maanen, Aline[UCL] Castella, Marie-Laure[UCL] Galon, Jérôme Van den Eynde, Marc[UCL] (2023) ESMO Congress 2023 — (Spain) Madrid
21. • Speech

    • 

    Homogeneity of pathological response (PR) and histopathological growth pattern (HGP) in resected colorectal liver metastases (CRLM) are associated with favorable survival outcome after surgery.

    Baldin, Paméla[UCL] Beniuga, Gabriella Carrasco, Javier De Cuyper, Astrid[UCL] Sinapi, Isabelle Hubert, Catherine[UCL] Navez, Benoît[UCL] Castella, Marie-Laure Van Maanen, Aline[UCL] Mlecnik, Bernhard Galon, Jerome Jouret-Mourin, Anna[UCL] Van den Eynde, Marc[UCL] (2022) 2022 ASCO Annual Meeting I —
22. • Speech

    • 

    Metastatic colorectal cancer has heterogeneous immune microenvironment and mutational expression

    Van den Eynde, Marc[UCL] Mlecnik, Bernhard Bindea, Gabriela Fredriksen, Tessa Lafontaine, Lucie Haicheur, Nacilla Marliot, Florence Debetancourt, Daphné[UCL] Mourin, Anne[UCL] Sempoux, Christine[UCL] Gigot, Jean-François[UCL] Hubert, Catherine[UCL] Kartheuser, Alex[UCL] Remue, Christophe[UCL] Léonard, Daniel[UCL] Carrasco, Javier Humblet, Yves[UCL] Pages, Franck Machiels, Jean-Pascal[UCL] Galon, Jerome (2016) Belgian Week of Gastroenterology - XXVIIIth edition — (Belgium) Bruxelles
23. • Journal article

    • 

    Identification by array comparative genomic hybridization of a new amplicon on chromosome 17q highly recurrent in BRCA1 mutated triple negative breast cancer

    Toffoli, Sébastien Bar, Isabelle Abdel-Sater, Fadi Delrée, Paul Hilbert, Pascale Cavallin, Frédéric Moreau, Fabrice Van Criekinge, Wim Lacroix-Triki, Magali Campone, Mario Martin, Anne-Laure Roché, Henri Machiels, Jean-Pascal[UCL] Carrasco, Javier[UCL] Canon, Jean-Luc (2014) Breast Cancer Research — Vol. 16, no.6, p. 466 (2014)
24. • Journal article

    • 

    Celyad's novel CAR T-cell therapy for solid malignancies.

    Lonez, Caroline Hendlisz, Alain Shaza, Leila Aftimos, Philippe Vouche, Michaël Donckier, Vincent Machiels, Jean-Pascal[UCL] Van den Eynde, Marc[UCL] Canon, Jean-Luc Carrasco, Javier Odunsi, Kunle Sahebjam, Solmaz Rottey, Sylvie Braun, Nathalie Verma, Bikash Gilham, David E Lehmann, Frédéric F (2018) Current research in translational medicine — Vol. 66, no.2, p. 53-56 (2018)
25. • Journal article

    • 

    Identification of a naturally processed HLA-A*02:01-restricted CTL epitope from the human tumor-associated antigen Nectin-4.

    Lopez, Marc Ghidouche, Abderrezak Rochas, Caroline Godelaine, Danièle Carrasco, Javier Colau, Didier[UCL] Hames, Gérald[UCL] Montero-Julian, Félix A Coulie, Pierre G.[UCL] Olive, Daniel (2016) Cancer Immunology, Immunotherapy : other biological response modifications — Vol. 65, no.10, p. 1177-1188 (2016)

Pages